0001640455-18-000080.txt : 20180621 0001640455-18-000080.hdr.sgml : 20180621 20180621171247 ACCESSION NUMBER: 0001640455-18-000080 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180619 FILED AS OF DATE: 20180621 DATE AS OF CHANGE: 20180621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pfeffer Cary CENTRAL INDEX KEY: 0001591092 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37998 FILM NUMBER: 18912452 MAIL ADDRESS: STREET 1: C/O ELEVEN BIOTHERAPEUTICS STREET 2: 215 FIRST STREET, SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jounce Therapeutics, Inc. CENTRAL INDEX KEY: 0001640455 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 454870634 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-259-3840 MAIL ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wf-form4_152961555067216.xml FORM 4 X0306 4 2018-06-19 0 0001640455 Jounce Therapeutics, Inc. JNCE 0001591092 Pfeffer Cary C/O THIRD ROCK VENTURES, LLC, 29 NEWBURY STREET, 3RD FLOOR BOSTON MA 02116 1 0 0 0 Stock Option (Right to Buy) 7.92 2018-06-19 4 A 0 13550 0 A 2028-06-19 Common Stock 13550.0 13550 D The option will vest in equal quarterly installments during the four quarters following the grant date, subject to the Reporting Person's continued service on the Issuer's board of directors. /s/ Anna L. Barry, Attorney-in-Fact 2018-06-21